PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications.
V. J. Sinibaldi
No relevant relationships to disclose
P. Huang
No relevant relationships to disclose
E. S. Antonarakis
No relevant relationships to disclose
M. A. Carducci
No relevant relationships to disclose
S. R. Denmeade
No relevant relationships to disclose
J. J. Kim
No relevant relationships to disclose
M. A. Eisenberger
No relevant relationships to disclose
D. Keizman
No relevant relationships to disclose